United States · FDA National Drug Code directory
Vigabatrin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-366_7fa314e2-0506-4061-9058-435a3b5df40d
- Product NDC
- 59651-366
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Vigabatrin
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210929
- Source listing expiry
- 20261231
Source-listed ingredients
- VIGABATRIN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 50 PACKET in 1 CARTON (59651-366-50) / 1 POWDER, FOR SOLUTION in 1 PACKET (59651-366-07) · 59651-366-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →